Skip to content
sellWeak

Orbimed Advisors LLC sold $913k of NPCE

owner at NeuroPace Inc. 64,653 shares at an average of $14.12, traded Apr 19, 2024, filed Apr 23, 2024.

Warning score
36
Value
$913k
64,653 shares
Holdings after
3,437,322
-2% from before
From 52-week low
+251%
low $3.98, close $13.98
From 52-week high
-20%
high $17.50, as of Apr 19, 2024

Score components

  • Role
    10% owner
    +12
  • Trade size
    $913k at market
    +24
  • Share of holdings sold
    Sold 1.8% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -45.8%, 3m -39.6%, 6m -57.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NPCEOct 12, 2026 · close 13.00
Since filing Apr 23, 2024: -7.2%SPY +58.4% · excess -65.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000947871-24-000410, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 19, 2024SOpen-market sale
Common Stockindirect: See Footnotes
-18,253$14.02$256k3,483,722Apr 23, 2024
Apr 22, 2024SOpen-market sale
Common Stockindirect: See Footnotes
-24,609$14.05$346k3,459,113Apr 23, 2024
Apr 23, 2024SOpen-market sale
Common Stockindirect: See Footnotes
-21,791$14.29$311k3,437,322Apr 23, 2024

Related signals

Other insiders at NeuroPace Inc and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
CHIEF MEDICAL OFFICER
$399k
25,000 shares
-33%
37Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$2.7M
168,136 shares
-5%
57Moderate
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$50M
5,270,845 shares
-100%
37Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$1.2M
224,138 shares
-4%
12Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$25k
4,082 shares
-0%
19Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$53k
8,598 shares
-0%
26Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$303k
46,426 shares
-1%
25Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$275k
39,684 shares
-1%
28Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$409k
29,206 shares
-1%
17Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$25k
1,781 shares
-0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Orbimed Advisors LLC sold $913k of NPCE | InsiderTell